SEC Form 4 · accession 0001209191-15-029570
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A/S Novo
10% Owner
Period of report
Mar 25, 2015
Accepted (ET)
Mar 26, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Mar 25, 2015 | X | 13,668 | $0.059 | A | 4,910,487 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SERIES A PREFERRED STOCK WARRANT (RIGHT TO BUY)F1 | $0.059 | Mar 25, 2015 | X | 13,668 | D | — | Jun 18, 2017 | COMMON STOCK | 13,668 | 0 | D |
Explanation of responses
- F1The warrant became exercisable for shares of the Issuer's Common Stock at an exercise price of $0.059 per share upon the closing of the Issuer's initial public offering (the "IPO Closing"). The number of shares reported herein gives effect to the one-for-5.9000 reverse stock split that occurred upon the IPO Closing.